Health for SaleStreaming Video - 2012
Are the world's largest drug firms, paradoxically, major obstacles to creating a healthier world? This program examines the business ethics of Big Pharma, the ten pharmaceutical companies whose pretax profits were more than the combined take of the 490 other Fortune 500 companies but which spend comparatively little on the health needs of the developing world. Spokespeople for the International Federation of Pharmaceutical Manufacturers and from WHO debate the impact of drug companies' patenting, pricing, and product development strategies on global public health, with topics that include the TRIPS agreements and "astroturfing" tactics that convince doctors to recognize new diseases that require new medications.
Publisher: New York, N.Y. : Films Media Group, , c2007